ES2056620T3 - Esteres de (r) (-)-carnitina y acil (r) (-)-carnitinas con acido beta hidroxibutirico y composiciones farmaceuticas que las contienen para inhibir la degeneracion neuronal, proteolisis de higado y para el tratamiento de coma. - Google Patents
Esteres de (r) (-)-carnitina y acil (r) (-)-carnitinas con acido beta hidroxibutirico y composiciones farmaceuticas que las contienen para inhibir la degeneracion neuronal, proteolisis de higado y para el tratamiento de coma.Info
- Publication number
- ES2056620T3 ES2056620T3 ES91830062T ES91830062T ES2056620T3 ES 2056620 T3 ES2056620 T3 ES 2056620T3 ES 91830062 T ES91830062 T ES 91830062T ES 91830062 T ES91830062 T ES 91830062T ES 2056620 T3 ES2056620 T3 ES 2056620T3
- Authority
- ES
- Spain
- Prior art keywords
- acid
- acil
- carnitines
- carnitine
- proteolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title abstract 8
- 206010010071 Coma Diseases 0.000 title abstract 2
- 210000004185 liver Anatomy 0.000 title abstract 2
- 230000017854 proteolysis Effects 0.000 title abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- -1 ISOVALERYL Chemical class 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 abstract 1
- 229940009098 aspartate Drugs 0.000 abstract 1
- 230000007850 degeneration Effects 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
LOS ESTERES DE CARNITINA-(R) (-) Y ACIL CARNITINAS-(R) (-) CON ACIDO BETA-HIDROXIBUTIRICO EN LA FORMA DE SALES ACEPTADAS FARMACEUTICAMENTE DE LA FORMULA (1) DONDE X ELEVADO ION DE UNA SAL ACEPTADA FARMACEUTICAMENTE, POR EJ. CLORURO, BROMURO, OROTATO, ASPARTATO ACIDO, CITRATO ACIDO, FOSFATO ACIDO, FUMARATO ACIDO, LACTATO, MALEATO ACIDO, OXALATATO ACIDO, SULFATO ACIDO Y GLUCOSOFOSFATO O EN LA FORMA DE SALES INTERNAS DE LA FORMULA (I'') DONDE R ES HIDROGENO O UN GRUPO ACILO RECTO O RAMIFICADO TENIENDO DE 2 A 5 ATOMOS DE CARBONO, COMO POR EJEMPLO ACETILO, PROPINOILO, BUTIRILO-N, ISOBUTIRILO Y ISOVALERILO, SON ACTIVOS EN LA INHIBICION DE DEGENERACION NEURONAS (COMO OCURRE EN LA DEMENCIA SENIL DE ALZHEIMER Y ENFERMEDAD DE PARKINSON), PROTEOLISIS DEL HIGADO Y EN EL TRATAMIENTO DEL COMA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT47669A IT1240775B (it) | 1990-02-23 | 1990-02-23 | Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2056620T3 true ES2056620T3 (es) | 1994-10-01 |
Family
ID=11261785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91830062T Expired - Lifetime ES2056620T3 (es) | 1990-02-23 | 1991-02-21 | Esteres de (r) (-)-carnitina y acil (r) (-)-carnitinas con acido beta hidroxibutirico y composiciones farmaceuticas que las contienen para inhibir la degeneracion neuronal, proteolisis de higado y para el tratamiento de coma. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0443996B1 (es) |
JP (1) | JP2930755B2 (es) |
AT (1) | ATE107624T1 (es) |
DE (1) | DE69102560T2 (es) |
DK (1) | DK0443996T3 (es) |
ES (1) | ES2056620T3 (es) |
HK (1) | HK1005868A1 (es) |
IT (1) | IT1240775B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1248321B (it) * | 1991-05-15 | 1995-01-05 | Sigma Tau Ind Farmaceuti | Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie |
IT1254135B (it) * | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica. |
IT1254136B (it) * | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica. |
IT1263013B (it) * | 1992-10-20 | 1996-07-23 | Avantgarde Spa | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. |
IT1261984B (it) * | 1993-06-22 | 1996-06-11 | Avantgarde Spa | Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
RU2224510C2 (ru) * | 1997-03-17 | 2004-02-27 | Би Ти Джи Интернэшнл Лимитед | Терапевтические композиции |
US6323237B1 (en) | 1997-03-17 | 2001-11-27 | Btg International Limited | Therapeutic compositions |
US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
US20020006959A1 (en) * | 2000-05-01 | 2002-01-17 | Henderson Samuel T. | Use of medium chain triglycerides for the treatment and prevention of Alzheimer's Disease and other diseases resulting from reduced Neuronal Metabolism |
KR101634083B1 (ko) | 2006-04-03 | 2016-06-28 | 액세라인크 | 나이와 관련된 기억 손상의 치료를 위한 케톤 생성 조성물의 용도 |
CN1995010B (zh) * | 2006-12-29 | 2012-12-12 | 辽宁科硕营养科技有限公司 | 一种合成丙酰左旋肉碱盐酸盐的方法 |
KR101335021B1 (ko) | 2007-07-31 | 2013-12-12 | 액세라인크 | 게놈 테스트의 용도 및 인지 기능 저하 치료용 케톤성 화합물 |
US9125881B2 (en) | 2008-07-03 | 2015-09-08 | Accera, Inc. | Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
CN112341331B (zh) * | 2019-08-07 | 2023-04-07 | 辽宁科硕营养科技股份有限公司 | 一种3-羟基丁酸盐及其制备方法与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1116037B (it) * | 1979-04-23 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico |
IT1145362B (it) * | 1980-03-06 | 1986-11-05 | Sigma Tau Ind Farmaceuti | Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico |
IT1209564B (it) * | 1984-06-29 | 1989-08-30 | Magis Farmaceutici | Derivati della l-carnitina o di l-acil carnitina. |
-
1990
- 1990-02-23 IT IT47669A patent/IT1240775B/it active IP Right Grant
-
1991
- 1991-02-21 DE DE69102560T patent/DE69102560T2/de not_active Expired - Fee Related
- 1991-02-21 ES ES91830062T patent/ES2056620T3/es not_active Expired - Lifetime
- 1991-02-21 AT AT91830062T patent/ATE107624T1/de not_active IP Right Cessation
- 1991-02-21 EP EP91830062A patent/EP0443996B1/en not_active Expired - Lifetime
- 1991-02-21 DK DK91830062.5T patent/DK0443996T3/da active
- 1991-02-22 JP JP3050644A patent/JP2930755B2/ja not_active Expired - Fee Related
-
1998
- 1998-06-05 HK HK98104950A patent/HK1005868A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0443996T3 (da) | 1994-07-25 |
DE69102560T2 (de) | 1994-10-13 |
JP2930755B2 (ja) | 1999-08-03 |
ATE107624T1 (de) | 1994-07-15 |
HK1005868A1 (en) | 1999-01-29 |
IT9047669A1 (it) | 1991-08-24 |
JPH0597785A (ja) | 1993-04-20 |
IT9047669A0 (it) | 1990-02-23 |
EP0443996B1 (en) | 1994-06-22 |
DE69102560D1 (de) | 1994-07-28 |
EP0443996A1 (en) | 1991-08-28 |
IT1240775B (it) | 1993-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2056620T3 (es) | Esteres de (r) (-)-carnitina y acil (r) (-)-carnitinas con acido beta hidroxibutirico y composiciones farmaceuticas que las contienen para inhibir la degeneracion neuronal, proteolisis de higado y para el tratamiento de coma. | |
ES2057837T3 (es) | Esteres de acil l-carnitinas con acido gamma-hidroxibutirico y composiciones farmaceuticas que los contienen para inhibir degeneracion neuronal y para el tratamiento de coma. | |
NO177674C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte propan-fosfinsyre-forbindelser | |
SG114293G (en) | Pharmaceutical compositions | |
ECSP045373A (es) | Sales de tolterodina | |
ES2056432T3 (es) | Ester de l-carnitina con acido gamma-hidroxibutirico y composiciones farmaceuticas que lo contienen para inhibir degeneracion neuronal y para el tratamiento de coma. | |
ES2078019T3 (es) | Amidas de alcanoil l-carnitina con aminoacidos y composiciones farmaceuticas que las contienen para promover regeneracion del tejido nervioso, inhibir degeneracion neuronal, mejorar el proceso de aprendimiento y memoria y para el tratamiento de coma. | |
DE69207479D1 (de) | Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen | |
KR940006576A (ko) | 에이즈 및 에이즈 관련 증후군 환자 및 무증후성 hiv혈청양성 환자치료를 위한 l-카르니틴 및 아실 l-카르니틴의 용도 | |
CA1075605A (en) | Infusion solutions with salts of glycerophosphates | |
YU244990A (sh) | Aminopiridinilmetanoli in aminometilpiridinamini ter srodne spojine, kot tudi postopek za njihovo pripravo | |
ES8800686A1 (es) | Un procedimiento para la preparacion de derivados aminoacidicos de l-fosfoserina. | |
TH8953B (th) | สารประกอบจำพวกฟอสโฟเนทที่มีควอเทอร์นารีไนโตรเจนอยู่ด้วยซึ่งเป็นสารชนิดใหม่, สารผสมทางเภสัชและวิธีบำบัดรักษาแคลเซียมและฟอสเฟทเมทาบอลิซึมที่ผิดปกติ | |
IT1248558B (it) | Derivati della fisovenina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
TH19223EX (th) | การผลิตและวิธีใช้อนุพันธ์ของแลคทอล | |
TH19223A (th) | การผลิตและวิธีใช้อนุพันธ์ของแลคทอล | |
TH439A (th) | อนุพันธ์เบนซอกซาชีน | |
ES478073A1 (es) | Un procedimiento de preparacion de benzamidas. | |
TH14595A (th) | เกลือเซฟาโลสพอริน และกรรมวิธีสำหรับเตรียมสารนั้น | |
IT1229854B (it) | Farmaci precursori della dopamina. | |
TH1593A (th) | แอลฟา-แอลคิล โพลิโอลีฟินิค คาร์บอกซิลิคแอซิด และอนุพันธ์ของสารนั้น ซึ่งใช้เป็นประโยชน์ในการรักษาโรคขี้เรื้อนกวาง | |
HUT59598A (en) | Process for producing preventive pharmaceutical compositions against myocardial ischemie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 443996 Country of ref document: ES |